Products Categories
    Product Certification&
    Enterprise Certification

  • Mr.pei
    Tel: +86-22-23754520

  • Mobile:+86 15076683720
  • Tel:+86-22-23754520
  • Fax:+86-22-23754520
  • Province/state:Tianjin
  • City:Tianjin
  • Street:Tianjin hi tech development in Xiqing District 2 Road No. 2 Building No. 5 414
  • MaxCard:
Home > Products >  Losmapimod

Losmapimod CAS NO.585543-15-3

  • FOB Price: USD: /Gram Get Latest Price
  • Min.Order: 1 Gram
  • Payment Terms: T/T
  • Available Specifications:

    reagent grade(1-5000)Gram

  • Product Details

Keywords

  • GW-856553 Structure
  • GW856553X Structure
  • GW 856553 supplier

Quick Details

  • ProName: Losmapimod
  • CasNo: 585543-15-3
  • Molecular Formula: C22H26FN3O2
  • Appearance: white solid powder
  • Application: Use as research only
  • DeliveryTime: in stock
  • PackAge: according to the clients requirement
  • Port: Tianjin
  • ProductionCapacity: 10 Kilogram/Month
  • Purity: More than 98%
  • Storage: Store at -20°C
  • Transportation: by sea or by air
  • LimitNum: 1 Gram
  • Valid Period: 2 years

Superiority

1.we are direct manufacturer and we have 7 years experience in this aera.
2.we can provide competitive price for every customer and guarantee the quality of our goods.
3.Specials are possible when client's order is big enough, including the discount policy;
4.we promise we will return your money if our product don't have effect.
5.Our company promise to deliver clients' package to his hands safely, or we'll cover the total loss and reship in time;
6. Our customers may buy our products again after they use our sample.

In stock ,>98% purity with low price. If you need HNMR\HPLC,please contact us!

Details

Losmapimod, also know as GW856553 or GW856553X, is a drug developed by GlaxoSmithKline which acts as a selective inhibitor of the enzyme family known as p38 mitogen-activated protein kinases. p38 mitogen-activated protein kinases are mediators of inflammation. A Phase II human clinical trial for the treatment of COPD (chronic obstructive pulmonary disease) is underway. Inhibiting these enzymes has been shown to produce antidepressant and antipsychotic effects in animal studies, with the mechanism thought to involve increased neurogenesis probably related to BDNF release. Losmapimod has completed Phase II human clinical trials for the treatment of depression although its safety and efficacy have yet to be proven in further trials. Losmapimod is also being studied for cardiovascular disease. A Phase II trial to study its effects in myocardial infarction (heart attack) is ongoing.

 

Tianjin Kailiqi Biopharma Technology Co., Ltd, is a professional manufacturer specialized in the production and distribution of active pharmaceutical ingredients and intermediates. Our company has strong R&D ability and production experience to provide the customers new APIs. We specialize in developing innovative processes for the synthesis of a wide range of products. We also undertake custom synthesis and contract manufacturing.if you are interest in,pls contact with me,we also have Lab,specifical in some hard synthesis.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog